norgesic forte
Generic: orphenadrine citrate, aspirin and caffeine
Labeler: poly pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
norgesic forte
Generic Name
orphenadrine citrate, aspirin and caffeine
Labeler
poly pharmaceuticals, inc.
Dosage Form
TABLET, MULTILAYER
Routes
Active Ingredients
aspirin 770 mg/1, caffeine 60 mg/1, orphenadrine citrate 50 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50991-999
Product ID
50991-999_472e3862-eab9-2279-e063-6394a90adb4c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075141
Listing Expiration
2026-12-31
Marketing Start
2019-04-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
50991999
Hyphenated Format
50991-999
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
norgesic forte (source: ndc)
Generic Name
orphenadrine citrate, aspirin and caffeine (source: ndc)
Application Number
ANDA075141 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 770 mg/1
- 60 mg/1
- 50 mg/1
Packaging
- 60 TABLET, MULTILAYER in 1 BOTTLE (50991-999-60)
Packages (1)
Ingredients (3)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "472e3862-eab9-2279-e063-6394a90adb4c", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["R16CO5Y76E", "3G6A5W338E", "X0A40N8I4S"], "rxcui": ["994535", "994537"], "spl_set_id": ["85a3b808-b476-f2f0-e053-2a91aa0af21f"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Poly Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, MULTILAYER in 1 BOTTLE (50991-999-60)", "package_ndc": "50991-999-60", "marketing_start_date": "20190401"}], "brand_name": "Norgesic Forte", "product_id": "50991-999_472e3862-eab9-2279-e063-6394a90adb4c", "dosage_form": "TABLET, MULTILAYER", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Centrally-mediated Muscle Relaxation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Muscle Relaxant [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "50991-999", "generic_name": "Orphenadrine Citrate, Aspirin and Caffeine", "labeler_name": "Poly Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Norgesic Forte", "active_ingredients": [{"name": "ASPIRIN", "strength": "770 mg/1"}, {"name": "CAFFEINE", "strength": "60 mg/1"}, {"name": "ORPHENADRINE CITRATE", "strength": "50 mg/1"}], "application_number": "ANDA075141", "marketing_category": "ANDA", "marketing_start_date": "20190401", "listing_expiration_date": "20261231"}